Clinical Trial Update: Drug-Eluting Stenting Followed by Cilostazol tREAtment Reduces SErious Adverse Cardiac Events (DECREASE-PCI) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial (DECREASE-PCI) evaluating drug-eluting stenting followed by cilostazol treatment in coronary artery disease was terminated; the study t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Cilostazol (Cilostazol)

Snippet

Sponsor: Seung-Jung Park | Conditions: Coronary Artery Disease | Phase 4 | Status: TERMINATED